Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis. (Record no. 25315404)

MARC details
000 -LEADER
fixed length control field 01557 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517054542.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201608s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1473-5687
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1097/MEG.0000000000000470
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Volonaki, Eleni
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20160815
245 00 - TITLE STATEMENT
Title Adalimumab as a second-line biological therapy in children with refractory ulcerative colitis.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. European journal of gastroenterology & hepatology
Date of publication, distribution, etc. Dec 2015
300 ## - PHYSICAL DESCRIPTION
Extent 1425-8 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adalimumab
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adolescent
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Anti-Inflammatory Agents, Non-Steroidal
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Child
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colectomy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colitis, Ulcerative
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Administration Schedule
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Evaluation
General subdivision methods
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Therapy, Combination
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Infliximab
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Remission Induction
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Retrospective Studies
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mutalib, Mohamed
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kiparissi, Fevronia
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shah, Neil
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Lindley, Keith J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Elawad, Mamoun
773 0# - HOST ITEM ENTRY
Title European journal of gastroenterology & hepatology
Related parts vol. 27
-- no. 12
-- p. 1425-8
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1097/MEG.0000000000000470">https://doi.org/10.1097/MEG.0000000000000470</a>
Public note Available from publisher's website

No items available.